Skip to main content
Veterinary Medicines

Gastazole 370 mg/g oral paste for horses

Authorised
  • Omeprazole

Product identification

Medicine name:
Omeprogard 370 mg/g Pasta voor oraal gebruik
Omeprogard 370 mg/g Pâte orale
Omeprogard 370 mg/g Paste zum Einnehmen
Gastazole 370 mg/g oral paste for horses
Active substance:
  • Omeprazole
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Omeprazole
    370.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BC01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 1 syringe
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 7 syringes
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 10 syringes
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 14 syringes
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 20 syringes
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 56 syringes
  • Immediate packageImmediate packaging: Opaque white pre-filled oral syringe containing 7.57g of paste composed of Barrel: HDPE & LLDPEBarrel Cap: LDPEPlunger: PolypropyleneRing: PolypropylenePlastic Seal: LDPEPackage sizesCarton box of 72 syringes

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V660589
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0658/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/04/2025
Download
Dutch (PDF)
Published on: 8/04/2024
French (PDF)
Published on: 8/04/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/04/2024
French (PDF)
Published on: 8/04/2024
German (PDF)
Published on: 8/04/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/04/2024
French (PDF)
Published on: 8/04/2024
German (PDF)
Published on: 8/04/2024

Combined File of all Documents

English (PDF)
Published on: 13/04/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."